WHO ICTRP trial
PBA (Ammonaps) in the prevention of intraocular pressure rise caused by…
EUCTR2015-000225-36-FI · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2015-000225-36-FI |
|---|---|
| Public title | PBA (Ammonaps) in the prevention of intraocular pressure rise caused by corticosteroid eye drops |
| Scientific title | PBA (4-phenylbutyrate) in the prevention of intraocular pressure increase caused by glucocorticoids - PBA in glucocorticoid glaucoma |
| Primary sponsor | Helsinki University Hospital |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Finland |
| Conditions | Intraocular pressure increase caused by glucocorticoid use in genetically predisposed patients;Therapeutic area: Diseases [C] - Eye Diseases [C11] |
| Interventions | Trade Name: Ammonaps tablets 500 mg Pharmaceutical Form: |
| Registration date | Jan 20, 2015 |
| Target size | 30 |
| Secondary IDs | hss198 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: